Efficacy of AIDS vaccine strategies in nonhuman primates

Medical Microbiology and Immunology

Volumn 194, Issue 4, 2005, Pages 201-206

  Überla, Klaus ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

AIDS; HIV; Primates; SIV; Vaccine

Indexed keywords

ADENOVIRUS VECTOR; DNA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INACTIVATED VACCINE; LIVE VACCINE; RECOMBINANT ENVELOPE PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VACCINIA VACCINE; VIRUS VECTOR;

ARTICLE; CLINICAL TRIAL; CORRELATION ANALYSIS; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGENICITY; NONHUMAN; POXVIRUS; PREDICTION; PRIMATE; PRIORITY JOURNAL; REMISSION; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VIRUS PARTICLE; VIRUS REPLICATION;

AIDS VACCINES; ANIMALS; DISEASE MODELS, ANIMAL; HIV INFECTIONS; HUMANS; PRIMATES; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

EID: 23844505910     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-005-0238-5     Document Type: Article

References (69)

1. Ahmed RK, Nilsson C, Wang Y, Lehner T, Biberfeld G, Thorstensson R (1999) Beta-chemokine production in macaques vaccinated with live attenuated virus correlates with protection against simian immunodeficiency virus (SIVsm) challenge. J Gen Virol 80:1569-1574
2. Amara RR, Villinger F, Altman JD, Lydy SL, O'Neil SP, Staprans SI, Montefiori DC, Xu Y, Herndon JG, Wyatt LS, Candido MA, Kozyr NL, Earl PL, Smith JM, Ma HL, Grimm BD, Hulsey ML, Miller J, McClure HM, McNicholl JM, Moss B, Robinson HL (2001) Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292:69-74
3. Baba TW, Jeong YS, Pennick D, Bronson R, Greene MF, Ruprecht RM (1995) Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267:1820-1825
4. Baba TW, Liska V, Khimani AH, Ray NB, Dailey PJ, Penninck D, Bronson R, Greene MF, McClure HM, Martin LN, Ruprecht RM (1999) Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat Med 5:194-203
5. Bachmann MF, Lutz MB, Layton GT, Harris SJ, Fehr T, Rescigno M, Ricciardi-Castagnoli P (1996) Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes. Eur J Immunol 26:2595-2600
6. Boyer JD, Wang B, Ugen KE, Agadjanyan M, Javadian A, Frost P, Dang K, Carrano RA, Ciccarelli R, Coney L, Williams WV, Weiner DB (1996) In vivo protective anti-HIV immune responses in nonhuman primates through DNA immunization. J Med Primatol 25:242-250
7. Chan WL, Rodgers A, Hancock RD, Taffs F, Kitchin P, Farrar G, Liew FY (1992) Protection in simian immunodeficiency virus-vaccinated monkeys correlates with anti-HLA class I antibody response. J Exp Med 176:1203-1207
8. Check E (2003) AIDS vaccines: back to 'plan A'. Nature 424:912-914
9. Clements JE, Montelaro RC, Zink MC, Amedee AM, Miller S, Trichel AM, Jagerski B, Hauer D, Martin LN, Bohm RP, Murphey-Corb M (1995) Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J Virol 69:2737-2744
10. Clerici M, Levin JM, Kessler HA, Harris A, Berzofsky JA, Landay AL, Shearer GM (1994) HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. JAMA 271:42-46
11. Cole KS, Rowles JL, Jagerski BA, Murphey-Corb M, Unangst T, Clements JE, Robinson J, Wyand MS, Desrosiers RC, Montelaro RC (1997) Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity. J Virol 71:5069-5079
12. Crotty S, Miller CJ, Lohman BL, Neagu MR, Compton L, Lu D, Lu FX, Fritts L, Lifson JD, Andino R (2001) Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors. J Virol 75:7435-7452
13. Daniel MD, Kirchhoff F, Czajak SC, Sehgal PK, Desrosiers RC (1992) Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258:1938-1941
14. Das AT, Verhoef K, Berkhout B (2004) A conditionally replicating virus as a novel approach toward an HIV vaccine. Methods Enzymol 388:359-379
15. Evans DT, Bricker JE, Desrosiers RC (2004) A novel approach for producing lentiviruses that are limited to a single cycle of infection. J Virol 78:11715-11725
16. Fowke KR, Nagelkerke NJ, Kimani J, Simonsen JN, Anzala AO, Bwayo JJ, MacDonald KS, Ngugi EN, Plummer FA (1996) Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 348:1347-1351
17. Giavedoni L, Ahmad S, Jones L, Yilma T (1997) Expression of gamma interferon by simian immunodeficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques. J Virol 71:866-872
18. Giavedoni LD, Planelles V, Haigwood NL, Ahmad S, Kluge JD, Marthas ML, Gardner MB, Luciw PA, Yilma TD (1993) Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection. J Virol 67:577-583
19. Graham BS (2002) Clinical trials of HIV vaccines. Annu Rev Med 53:207-221
20. Gundlach BR, Linhart H, Dittmer U, Sopper S, Reiprich S, Fuchs D, Fleckenstein B, Hunsmann G, Stahl-Hennig C, Überla K (1997) Construction, Replication, and Immunogenic Properties of a Simian Immunodeficiency Virus expressing Interleukin 2. J Virol 71:2225-2232
21. Gundlach BR, Reiprich S, Sopper S, Means RE, Dittmer U, Matz-Rensing K, Stahl-Hennig C, Überla K (1998) Env-independent protection induced by live, attenuated simian immunodeficiency virus vaccines. J Virol 72:7846-7851
22. Hacein-Bey-Abina S, von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, de Saint BG, Alexander I, Wintergerst U, Frebourg T, Aurias A, Stoppa-Lyonnet D, Romana S, Radford-Weiss I, Gross F, Valensi F, Delabesse E, Macintyre E, Sigaux F, Soulier J, Leiva LE, Wissler M, Prinz C, Rabbitts TH, Le Deist F, Fischer A, Cavazzana-Calvo M (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415-419
23. Hanke T, Samuel RV, Blanchard TJ, Neumann VC, Allen TM, Boyson JE, Sharpe SA, Cook N, Smith GL, Watkins DI, Cranage MP, McMichael AJ (1999) Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen. J Virol 73:7524-7532
24. Harris SJ, Gearing AJ, Layton GT, Adams SE, Kingsman AJ (1992) Enhanced proliferative cellular responses to HIV-1 V3 peptide and gp120 following immunization with V3:Ty virus-like particles. Immunology 77:315-321
25. Heeney JL, Koopman G, Rosenwirth B, Bogers W, van Dijk J, Nieuwenhuis I, Niphuis H, ten Haaft P, Hanke T, Rhodes G, Berglund P, Burny A, Bex F, Sutter G, Liljestrom P (2000) A vaccine strategy utilizing a combination of three different chimeric vectors which share specific vaccine antigens. J Med Primatol 29:268-273
26. Horton H, Vogel TU, Carter DK, Vielhuber K, Fuller DH, Shipley T, Fuller JT, Kunstman KJ, Sutter G, Montefiori DC, Erfle V, Desrosiers RC, Wilson N, Picker LJ, Wolinsky SM, Wang C, Allison DB, Watkins DI (2002) Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239. J Virol 76:7187-7202
27. Hu SL, Polacino P, Stallard V, Klaniecki J, Pennathur S, Travis BM, Misher L, Kornas H, Langlois AJ, Morton WR, Benveniste RE (1996) Recombinant subunit vaccines as an approach to study correlates of protection against primate lentivirus infection. Immunol Lett 51:115-119
28. Kang SM, Yao Q, Guo L, Compans RW (2003) Mucosal immunization with virus-like particles of simian immunodeficiency virus conjugated with cholera toxin subunit B. J Virol 77:9823-9830
29. Kuate S, Stahl-Hennig C, Haaft PT, Heeney J, Überla K (2003) Single cycle immunodeficiency viruses provide strategies for uncoupling in vivo expression levels from viral replicative capacity and for mimicking live attenuated SIV vaccines. Virology 313:653-662
30. Langlois AJ, Desrosiers RC, Lewis MG, KewalRamani VN, Littman DR, Zhou JY, Manson K, Wyand MS, Bolognesi DP, Montefiori DC (1998) Neutralizing antibodies in sera from macaques immunized with attenuated simian immunodeficiency virus. J Virol 72:6950-6955
31. Layton GT, Harris SJ, Gearing AJ, Hill-Perkins M, Cole JS, Griffiths JC, Burns NR, Kingsman AJ, Adams SE (1993) Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-like particles. J Immunol 151:1097-1107
32. Le Grand R, Vogt G, Vaslin B, Roques P, Theodoro F, Aubertin AM, Dormont D (1992) Specific and non-specific immunity and protection of macaques against SIV infection. Vaccine 10:873-879
33. Lifson JD, Piatak M Jr, Rossio JL, Bess J Jr, Chertova E, Schneider D, Kiser R, Coalter V, Poore B, Imming R, Desrosiers RC, Henderson LE, Arthur LO (2002) Whole inactivated SIV virion vaccines with functional envelope glycoproteins: safety, immunogenicity, and activity against intrarectal challenge. J Med Primatol 31:205-216
34. Lohman BL, McChesney MB, Miller CJ, McGowan E, Joye SM, Van Rompay KK, Reay E, Antipa L, Pedersen NC, Marthas ML (1994) A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J Virol 68:7021-7029
35. Lu S, Arthos J, Montefiori DC, Yasutomi Y, Manson K, Mustafa F, Johnson E, Santoro JC, Wissink J, Mullins JI, Haynes JR, Letvin NL, Wyand M, Robinson HL (1996) Simian immunodeficiency virus DNA vaccine trial in macaques. J Virol 70:3978-3991
36. Lu X, Kiyono H, Lu D, Kawabata S, Torten J, Srinivasan S, Dailey PJ, McGhee JR, Lehner T, Miller CJ (1998) Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251. AIDS 12:1-10
37. Marthas ML, Sutjipto S, Higgins J, Lohman B, Torten J, Luciw PA, Marx PA, Pedersen NC (1990) Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV. J Virol 64:3694-3700
38. Metzner KJ, Jin X, Lee FV, Gettie A, Bauer DE, Di Mascio M, Perelson AS, Marx PA, Ho DD, Kostrikis LG, Connor RI (2000) Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. J Exp Med 191:1921-1931
39. Miller CJ, McChesney MB, Lu X, Dailey PJ, Chutkowski C, Lu D, Brosio P, Roberts B, Lu Y (1997) Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIV-mac239. J Virol 71:1911-1921
40. Montefiori DC, Baba TW, Li A, Bilska M, Ruprecht RM (1996) Neutralizing and infection-enhancing antibody responses do not correlate with the differential pathogenicity of SIVmac239delta3 in adult and infant rhesus monkeys. J Immunol 157:5528-5535
41. Mossman SP, Bex F, Berglund P, Arthos J, O'Neil SP, Riley D, Maul DH, Bruck C, Momin P, Burny A, Fultz PN, Mullins JI, Liljestrom P, Hoover EA (1996) Protection against lethal simian immunodeficiency virus SIV-smmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. J Virol 70:1953-1960
42. Muhl T, Krawczak M, ten Haaft P, Hunsmann G, Sauermann U (2002) MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys. J Immunol 169:3438-3446
43. Murphy CG, Lucas WT, Means RE, Czajak S, Hale CL, Lifson JD, Kaur A, Johnson RP, Knipe DM, Desrosiers RC (2000) Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus. J Virol 74:7745-7754
44. Nakashima H, Yamamoto N, Masuda M, Fujii N (1993) Defensins inhibit HIV replication in vitro. AIDS 7:1129
45. Norley S, Beer B, Binninger-Schinzel D, Vogel T, Hohn O, Seibold E, Radke D, Cosma C, Kurth R (2002) Vaccine development using the simian immunodeficiency virus model for AIDS. Intervirology 45:267-274
46. Petry H, Dittmer U, Stahl Hennig C, Coulibaly C, Makoschey B, Fuchs D, Wachter H, Tolle T, Morys Wortmann C, Kaup FJ, Jurkiewitz E, Lüke W, Hunsmann G (1995) Reactivation of human immunodeficiency virus type 2 in macaques after simian immunodeficiency virus SIVmac superinfection. J Virol 69:1564-1574
47. Petry H, Stahl-Hennig C, Dittmer U, Jones D, Farrar G, Wachter H, Fuchs D, Nisslein T, Jurkiewicz E, Hunsmann G, Luke W (1998) A subunit vaccine consisting of gp130 oligomers but not of gp130 monomers protects rhesus macaques against productive infection with SIVmac32H. AIDS 12:329-330
48. Pilgrim AK, Pantaleo G, Cohen OJ, Fink LM, Zhou JY, Zhou JT, Bolognesi DP, Fauci AS, Montefiori DC (1997) Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection. J Infect Dis 176:924-932
49. Pinto LA, Sullivan J, Berzofsky JA, Clerici M, Kessler HA, Landay AL, Shearer GM (1995) ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J Clin Invest 96:867-876
50. Putkonen P, Nilsson C, Hild K, Benthin R, Cranage M, Aubertin AM, Biberfeld G (1993) Whole inactivated SIV vaccine grown on human cells fails to protect against homologous SIV grown on simian cells. J Med Primatol 22:100-103
51. Putkonen P, Quesada-Rolander M, Leandersson AC, Schwartz S, Thorstensson R, Okuda K, Wahren B, Hinkula J (1998) Immune responses but no protection against SHIV by gene-gun delivery of HIV-1 DNA followed by recombinant subunit protein boosts. Virology 250:293-301
52. Rose NF, Marx PA, Luckay A, Nixon DF, Moretto WJ, Donahoe SM, Montefiori D, Roberts A, Buonocore L, Rose JK (2001) An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell 106:539-549
53. Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, Walker BD (1997) Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278:1447-1450
54. Rowland-Jones S, Sutton J, Ariyoshi K, Dong T, Gotch F, McAdam S, Whitby D, Sabally S, Gallimore A, Corrah T (1995) HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med 1:59-64
55. Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, Lifton MA, Racz P, Tenner-Racz K, Dalesandro M, Scallon BJ, Ghrayeb J, Forman MA, Montefiori DC, Rieber EP, Letvin NL, Reimann KA (1999) Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283:857-860
56. Sharpe S, Polyanskaya N, Dennis M, Sutter G, Hanke T, Erfle V, Hirsch V, Cranage M (2001) Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity. J Gen Virol 82:2215-2223
57. Shen L, Chen ZW, Miller MD, Stallard V, Mazzara GP, Panicali DL, Letvin NL (1991) Recombinant virus vaccine-induced SIV-specific CD8+ cytotoxic T lymphocytes. Science 252:440-443
58. Shiver JW, Fu TM, Chen L, Casimiro DR, Davies ME, Evans RK, Zhang ZQ, Simon AJ, Trigona WL, Dubey SA, Huang L, Harris VA, Long RS, Liang X, Handt L, Schleif WA, Zhu L, Freed DC, Persaud NV, Guan L, Punt KS, Tang A, Chen M, Wilson KA, Collins KB, Heidecker GJ, Fernandez VR, Perry HC, Joyce JG, Grimm KM, Cook JC, Keller PM, Kresock DS, Mach H, Troutman RD, Isopi LA, Williams DM, Xu Z, Bohannon KE, Volkin DB, Montefiori DC, Miura A, Krivulka GR, Lifton MA, Kuroda MJ, Schmitz JE, Letvin NL, Caulfield MJ, Bett AJ, Youil R, Kaslow DC, Emini EA (2002) Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415:331-335
59. Stahl-Hennig C, Gundlach BR, Dittmer U, ten Haaft P, Heeney J, Zou W, Emilie D, Sopper S, Überla K (2003) Replication, Immunogenicity, and Protective Properties of Live- Attenuated Simian Immunodeficiency Viruses Expressing Interleukin-4 or Interferon-gamma. Virology 305:473-485
60. Stahl-Hennig C, Steinman RM, ten Haaft P, Überla K, Stolte N, Saeland S, Tenner-Racz K, Racz P (2002) The simian immunodeficiency virus dellaNef vaccine, after application to the tonsils of Rhesus macaques, replicates primarily within CD4(+) T cells and elicits a local perforin-positive CD8(+) T-cell response. J Virol 76:688-696
61. Steinstraesser L, Tippler B, Mertens J, Lamme E, Homann HH, Lehnhardt M, Wildner O, Steinau HU, Überla K (2005) Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides. Retrovirology 2:2
62. Stott EJ (1991) Anti-cell antibody in macaques. Nature 353:393
63. Tenner-Racz K, Hennig CS, Überla K, Stoiber H, Ignatius R, Heeney J, Steinman RM, Racz P (2004) Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus. Proc Natl Acad Sci USA 101:3017-3022
64. Wagner R, Boltz T, Deml L, Modrow S, Wolf H (1993) Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses. J Gen Virol 74:1261-1269
65. Wagner R, Deml L, Schirmbeck R, Niedrig M, Reimann J, Wolf H (1996) Construction, expression, and immunogenicity of chimeric HIV-1 virus-like particles. Virology 220:128-140
66. Wyand MS, Manson KH, Garcia-Moll M, Montefiori D, Desrosiers RC (1996) Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J Virol 70:3724-3733
67. Yao Q, Zhang R, Guo L, Li M, Chen C (2004) Th cell-independent immune responses to chimeric hemagglutinin/simian human immunodeficiency virus-like particles vaccine. J Immunol 173:1951-1958
68. Zhang L, Yu W, He T, Yu J, Caffrey RE, Dalmasso EA, Fu S, Pham T, Mei J, Ho JJ, Zhang W, Lopez P, Ho DD (2002) Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 298:995-1000
69. Zhang ZQ, Fu TM, Casimiro DR, Davies ME, Liang X, Schleif WA, Handt L, Tussey L, Chen M, Tang A, Wilson KA, Trigona WL, Freed DC, Tan CY, Horton M, Emini EA, Shiver JW (2002) Mamu-A*01 allele-mediated attenuation of disease progression in simian-human immunodeficiency virus infection. J Virol 76:12845-12854